Annovis Bio, Inc. (ANVS)

Annovis Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	53	69	192	110	142	52
Market Cap Growth	-34.29%	-63.84%	75.03%	-23.01%	174.06%	-
Enterprise Value	35	57	186	78	95	43
Last Close Price	2.70	5.03	18.70	13.43	17.58	7.54
PB Ratio	2.87	7.46	-24.76	3.87	3.20	6.89
P/TBV Ratio	2.87	7.46	-	3.87	3.20	6.89
Quick Ratio	6.11	2.72	1.35	3.69	30.33	13.96
Current Ratio	7.65	3.59	2.39	4.68	30.54	14.04
Return on Equity (ROE)	-365.03%	-3159.09%	-546.40%	-69.57%	-55.68%	-180.82%
Return on Assets (ROA)	-111.68%	-138.26%	-121.77%	-38.88%	-33.58%	-89.86%
Return on Capital (ROIC)	-178.51%	-2143.41%	-273.63%	-43.79%	-34.92%	-126.89%
Earnings Yield	-57.51%	-35.43%	-29.29%	-23.10%	-10.17%	-10.51%
Buyback Yield / Dilution	-55.91%	-35.60%	-10.55%	-7.03%	-20.88%	-2132.36%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q